Blindness may no longer require surgery in the future, as scientists explore a new experimental approach using microscopic gold particles.
Researchers have developed ultra-small gold nanoparticles that can be injected directly into the eye.
Once inside, these particles are designed to respond to infrared light and interact with damaged retinal cells.
In early explanations, scientists suggest that this reaction could potentially reactivate parts of the retina that are no longer functioning properly.
Moreover, the approach is being studied as a less invasive alternative to traditional treatments such as retinal surgery or electronic implants.
Unlike existing methods, no bulky devices are required, and the procedure is expected to be minimally invasive if proven safe for human use.
The concept is to stimulate vision pathways rather than replace them.
According to researchers cited in ACS Nano, the method involves a gold nanoparticle-based retinal prosthesis aimed at restoring vision function.
The study, led by Ma, H. and colleagues, highlights how nanotechnology may be used to interact directly with eye cells in new ways that were previously not possible.
Furthermore, scientists believe this innovation could one day benefit millions of people suffering from blindness and severe retinal diseases.
While current results remain in the experimental stage, early findings have been described as promising and highly encouraging for future development.
In addition, researchers are continuing to refine how the nanoparticles respond to light signals and how accurately they can stimulate retinal activity without damaging surrounding tissue.
